This hybrid workshop will examine how researchers could more meaningfully engage and sustain interactions with historically underrepresented communities in research to foster their participation in genomics and precision health studies. Learn more at https://www.nationalacademies.org/event/42785_07-2024_sustaining-community-engagement-in-genomics-research-a-workshop.

The 2024 Next Generation Dx Summit will explore trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve the standard of care in medicine. Learn more at https://www.nextgenerationdx.com/.

The Individualizing Medicine Conference is dedicated to unraveling the intricacies of population -omics, digital -omics, functional -omics, and rare disease -omics, and their vital role in patient care. Learn more at https://individualizingmedicineconference.mayo.edu/.

McDermott+Consulting organizes the +Dx Diagnostics Forum to provide members of the laboratory diagnostics community with key insights from industry innovators, thought leaders, regulators, and decision-makers. The forum covers the regulatory, legislative, and market developments shaping the future of the diagnostics space.

The Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship convenes an audience of leading cancer researchers, entrepreneurs, investors, business executives, and advocates.

The Advancing Precision Medicine Annual Conference and Exhibition is designed to serve as a hub of knowledge exchange, collaboration, and innovation for researchers, clinicians, and industry professionals.

A highly interactive meeting, the Think Tank on Advancing Precision Medicine in Rare Cancers will bring together clinicians, researchers, industry, government, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.